SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001070698-13-000048
Filing Date
2013-07-05
Accepted
2013-07-03 20:37:25
Documents
5
Period of Report
2013-07-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K FILED JULY 3, 2013 rptp_8k_prosupp_070313.htm 8-K 21847
2 AMENDED AND RESTATED SALES AGREEMENT DATED 7-3-13 BETWEEN RAPTOR PHARMA AND COWE rptp_cowen_atm070313.htm EX-1.1 239664
3 OPINION OF LATHAM & WATKINS LLP rptp_8k_atm070313_lwconsent.htm EX-5.1 21122
4 image00002.jpg GRAPHIC 2448
5 image00003.jpg GRAPHIC 1849
  Complete submission text file 0001070698-13-000048.txt   290223
Mailing Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949
Business Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949 415-382-1390
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-25571 | Film No.: 13954654
SIC: 2834 Pharmaceutical Preparations